In the past few years, angiotensin II-receptor blockers have become available and are being heavily marketed and increasingly used. In various ways they differ from angiotensin-converting enzyme inhibitors (ACEIs). Until outcome data are available, they should continue to be used primarily in patients who should receive an ACEI but cannot tolerate the drug because of cough.
- Angiotensin II
- Angiotensin II-receptor blockers
- Angiotensin-converting enzyme inhibitors
ASJC Scopus subject areas
- Internal Medicine